Kangli Guo

607 citations
13 papers · 472 indexed · 1 hit paper · h-index 10

Kangli Guo

12 papers receiving 467 citations

Hit Papers

Janus nanoparticles targeting extracellular polymeric sub...1102023202620242025255075100

Peers

Kangli Guo
Comparison fields: 5 of 78
  • Biomaterials 123
  • Biomedical Engineering 291
  • Molecular Medicine 23
  • Immunology 62
  • Materials Chemistry 134
Replace Shameer Pillarisetti with:
Shameer Pillarisetti South Korea
Zhenzhong Zhang China
Yun Meng China
Fengfeng Xiao China
Miao Feng China
Duotian Qin United States
Wenxiang Zhu China
Parinaz Fathi United States
Laurence Burroughs United Kingdom
Kangli Guo relative to Shameer Pillarisetti South Korea Shameer Pillarisetti's profile →
Citations per field
00.5×1.5×
Shameer Pillarisetti · 1×
Citations per year

Countries citing papers authored by Kangli Guo

Since Specialization
Citations

This map shows the geographic impact of Kangli Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kangli Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kangli Guo more than expected).

Fields of papers citing papers by Kangli Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kangli Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kangli Guo. The network helps show where Kangli Guo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kangli Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kangli Guo Line = papers co-authored together Kangli Guo links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1 20250
2 202416
3 20244
4 202410
5 20249
6 202376
7
Janus nanoparticles targeting extracellular polymeric substance achieve flexible elimination of drug-resistant biofilmsbreakdown →
2023110
8 202380
9 202335
10 20232
11 202292
12 201913
13 201925

About Kangli Guo

Kangli Guo is a scholar working on Biomaterials, Biomedical Engineering and Molecular Medicine, having authored 13 papers that have together received 472 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (8 papers), Immune cells in cancer (3 papers), Advanced Nanomaterials in Catalysis (3 papers), Nanoparticle-Based Drug Delivery (2 papers), Tissue Engineering and Regenerative Medicine (2 papers), Immunotherapy and Immune Responses (2 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers) and Hydrogels: synthesis, properties, applications (1 paper). The work is most often cited by research in Biomaterials (123 citations), Biomedical Engineering (291 citations) and Molecular Medicine (23 citations). Kangli Guo has collaborated with scholars based in China and Macao. Frequent co-authors include Nana Zhao, Fu‐Jian Xu, Xiaoyi Zhao, Kai Zhang, Zhiwen Liu, Xiaokang Ding, Ying Wang, Xu Chen, Meiwan Chen and Shun Duan. Their work appears in journals such as Advanced Materials, Nature Communications and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026